Trade Summary

1 week ago, Quisel John D, serving as Chief Executive Officer at Disc Medicine, Inc. (IRON), sold 34,000 shares at $70.21 per share, for a total transaction value of $2,387,295.70. Following this transaction, Quisel John D now holds 226,064 shares of IRON.

This sale represents a 13.07% decrease in Quisel John D's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 18, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 23, 2026 at 5:16 PM ET, 5 days after the trade was made.

Disc Medicine, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.